FDA Appoints Acting Director of Medical Device Security, Signaling Increased Commitment to Medical Device Cybersecurity The U.S. Food and Drug Administration (FDA) announced that the newly-created post of Acting Director of Medical Device Security has been filled by Kevin Fu, a University of Michigan associate professor and founder of the Archimedes Center for Medical Device Security. Fu, who was appointed for a one-year term, is expected to “work to bridge the gap between medicine and computer science and help manufacturers protect medical devices from digital security threats.” 1 The creation of the position reflects the FDA’s ongoing efforts to ensure the safety and effectiveness of Internet of Things and medical devices such as insulin pumps, pacemakers, and hospital imaging machines. These devices, which increasingly rely on software and the cloud to operate, are particularly vulnerable to threat actors targeting hospitals and other medical providers with ransomware and other attacks. Such attacks have been on the rise, particularly given the shift to telehealth and remote operation of medical devices in the wake of COVID-19.